Concepedia

Jeff P. Sharman

JP

Statistics

Publications

142

Citations

14.3K

H-Index

45

Active since

1997

Affiliations

Willamette Valley Cancer Institute and Research Center(Current)

The University of Texas MD Anderson Cancer Center

Cornell University

Stanford University

Jeff P. Sharman is an author at Willamette Valley Cancer Institute and Research Center specializing in oncology, medicine, and immunology.

Top concepts

MedicineOncologyImmunologyPharmacotherapyCancer ResearchImmunotherapyCancer TherapyHealthPathologyClinical Trials

Publications per year

1997–2025

142

Publications

142

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

Richard R. Furman, Jeff P. Sharman, Steven Coutré et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

Ranjana H. Advani, Joseph J. Buggy, Jeff P. Sharman et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan et al. · Blood · 2013 · 783 citations · Full text

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

Jonathan W. Friedberg, Jeff P. Sharman, John Sweetenham et al. · Blood · 2009 · 734 citations · Full text

Rows per page

1–5 of 142